Peter Cicala - 07 Feb 2025 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role
Director
Signature
/s/ Peter Cicala
Issuer symbol
ERNA
Transactions as of
07 Feb 2025
Net transactions value
$0
Form type
4
Filing time
10 Feb 2025, 19:00:08 UTC
Previous filing
29 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Stock Option (Right to buy) Award $0 +51,485 $0.000000 51,485 07 Feb 2025 Common Stock 51,485 $0.3400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.